Safety and Efficacy of Laparoscopic Vertical Clip Gastroplasty: Early Results of an Italian Multicenter Study
Articolo
Data di Pubblicazione:
2023
Citazione:
Safety and Efficacy of Laparoscopic Vertical Clip Gastroplasty: Early Results of an Italian Multicenter Study / Gentileschi, P.; Campanelli, M.; Sensi, B.; Benavoli, D.; Arcudi, C.; Siragusa, L.; Bianciardi, E.; Uccelli, M.; Di Capua, F.; Olmi, S.. - In: OBESITY SURGERY. - ISSN 0960-8923. - 33:1(2023), pp. 303-312. [10.1007/s11695-022-06364-7]
Abstract:
Purpose: Sleeve gastrectomy, the most commonly performed bariatric surgery procedure, carries limitations both short term including postoperative complications such as hemorrhage and gastric fistula and long term such as weight regain and gastroesophageal reflux. A new procedure has been proposed to overcome many of these limitations: laparoscopic vertical clip gastroplasty (LVCG) with BariClip. Materials and Methods: Fifty patients were offered LVCG and enrolled for a feasibility study in two referral bariatric centers. Indication was given as for sleeve gastrectomy, after a multidisciplinary path evaluating age, gender, BMI, comorbidities, eating behaviors, and gastroesophageal reflux. The primary outcome was major postoperative complications. Secondary outcomes included weight loss, incidence of de-novo GERD, and comorbidity resolution. Results: Patients had a mean age of 44 years and mean BMI of 37 kg/m2 ± 6.2. All procedures were performed successfully in laparoscopy, with no conversion or intraoperative adverse events. The overall major postoperative complication rate was 6%. Re-operation was required in three patients for slippage. No mortality occurred. Excess weight loss, excess BMI loss, and total weight loss at 6 months were 36%, 57%, and 22%, respectively. There was no instance of de-novo GERD. Resolution of hypertension occurred in 50% of cases, OSAS in 65% of cases, and DMII in 80% of cases. Conclusion: The safety of LVCG procedure has been reproduced in a multicentric, multi-surgeon study. Weight loss outcomes appear promising. A randomized trial is needed to fully assess the benefits of LVCG. Graphical Abstract: [Figure not available: see fulltext.].
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Gentileschi, P.; Campanelli, M.; Sensi, B.; Benavoli, D.; Arcudi, C.; Siragusa, L.; Bianciardi, E.; Uccelli, M.; Di Capua, F.; Olmi, S.
Link alla scheda completa:
Pubblicato in: